home / stock / wve / wve news


WVE News and Press, Wave Life Sciences Ltd. From 11/09/20

Stock Information

Company Name: Wave Life Sciences Ltd.
Stock Symbol: WVE
Market: NASDAQ
Website: wavelifesciences.com

Menu

WVE WVE Quote WVE Short WVE News WVE Articles WVE Message Board
Get WVE Alerts

News, Short Squeeze, Breakout and More Instantly...

WVE - Wave Life Sciences Ltd. (WVE) CEO Paul Bolno on Q3 2020 Results - Earnings Call Transcript

Wave Life Sciences Ltd. (WVE) Q3 2020 Earnings Conference Call November 9, 2020 8:30 a.m. ET Company Participants Graham Morrell - IR Paul Bolno - President and CEO Mike Panzara - Chief Medical Officer, Head of Therapeutics Discovery and Development Dave Gaiero - Interim CFO Chandra Vargeese ...

WVE - Wave Life Sciences EPS misses by $0.13, misses on revenue

Wave Life Sciences (WVE): Q3 GAAP EPS of -$0.86 misses by $0.13.Revenue of $3.45M (+17.7% Y/Y) misses by $7.67M.Press Release For further details see: Wave Life Sciences EPS misses by $0.13, misses on revenue

WVE - Wave Life Sciences Reports Third Quarter 2020 Financial Results and Provides Business Update

Results from all cohorts of PRECISION-HD1 and PRECISION-HD2 clinical trials and initial OLE data on track for 1Q 2021 Dosing in three new clinical trials with novel compounds incorporating PN chemistry and targeting SNP3 in HD, C9orf72...

WVE - Wave Life Sciences to Webcast Conference Call of Third Quarter 2020 Financial Results on November 9, 2020

CAMBRIDGE, Mass., Oct. 26, 2020 (GLOBE NEWSWIRE) -- Wave Life Sciences Ltd. (Nasdaq: WVE), a clinical-stage genetic medicines company committed to delivering life-changing treatments for people battling devastating diseases, announced today that management will host a live webcast and confe...

WVE - Wave Life Sciences to Present at the Chardan Virtual 4th Annual Genetic Medicines Conference

CAMBRIDGE, Mass., Sept. 28, 2020 (GLOBE NEWSWIRE) -- Wave Life Sciences Ltd. (Nasdaq: WVE), a clinical-stage genetic medicines company committed to delivering life-changing treatments for people battling devastating diseases, announced today that Paul Bolno, MD, MBA, President and Chief Exe...

WVE - JKS, DQ, ACB and LAC among midday movers

Gainers: JinkoSolar Holding (JKS) +18%.HireQuest (HQI) +16%.American Well (AMWL) +16%.Hilltop Holdings (HTH) +13%.Daqo New Energy (DQ) +12%.Perion Network (PERI) +12%.Qutoutiao (QTT) +11%.Entercom Communications (ETM) +10%.Aerpio Pharmaceuticals (ARPO) +9%.Annexon (ANNX) +8%.Lo...

WVE - American Well, MediciNova among major healthcare gainers, AC Immune, Wave Life Sciences leads losers' pack

Gainers: American Well (AMWL) +17%, MediciNova (MNOV) +13%, Mallinckrodt (MNK) +7%, Capricor Therapeutics (CAPR) +8%, Adamas Pharmaceuticals (ADMS) +6%.Losers: AC Immune (ACIU) -42%, Wave Life Sciences (WVE) -34%, Rockwell Medical (RMTI)&...

WVE - TSLA, GMAB among premarket losers

AC Immune SA (ACIU) -43% as semorinemab flunks Alzheimer's study.Wave Life Sciences (WVE) -31% after pricing equity offering.Aurora Cannabis (ACB) -17% on soft revenue outlook.NanoVibronix (NAOV) -17% after increasing the size of the previous publi...

WVE - Wave Life Sciences under pressure after equity offering pricing

Wave Life Sciences (WVE) tanks ~27% in premarket, in reaction to pricing of its previously announced equity offering of 8.3M shares at $12/share, with gross proceeds of $100M.Offer price represents a discount of around 24% to its last close price of $15.84.Underwriters have an optio...

WVE - Wave Life Sciences Prices $100 Million Public Offering of Ordinary Shares

CAMBRIDGE, Mass., Sept. 23, 2020 (GLOBE NEWSWIRE) -- Wave Life Sciences Ltd. (Nasdaq: WVE), a clinical-stage genetic medicines company committed to delivering life-changing treatments for people battling devastating diseases, announced today the pricing of its previously announced underwrit...

Previous 10 Next 10